Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Status:
Completed
Trial end date:
2017-05-26
Target enrollment:
Participant gender:
Summary
This Phase 2 clinical trial is a multi-center, randomized, double-blind, placebo-controlled,
multiple-dose, parallel-cohort study to assess the efficacy, safety and tolerability of
VDA-1102 in the treatment of actinic keratosis (AK) on the head of male and female adult
subjects.